July 14th at 1 pm, don’t miss Ana Isabel Silva "Novel therapeutic approaches for bladder cancer" at the A0.02 auditorium in UMinho’s School of Medicine.

Your research data is valuable to the University of Minho, so organizing and sharing it securely increases its impact, promotes good Open Science practices and enhances reuse by other researchers.

Sandro Queirós (SQ) graduated in Biomedical Engineering in 2013 by the University of Minho (Portugal). In 2018, he completed a joint Ph.D. degree in Biomedical Engineering by the University of Minho (Portugal) and in Biomedical Sciences by KU Leuven (Belgium). Since 2018, SQ is a full-time researcher at ICVS, having been granted an FCT-funded junior research position in 2020.

July 28th at 1 pm, don’t miss João Machado “Assessing astrocytic modulation of neuronal activity in cortico-limbic circuits” at the A0.02 auditorium in UMinho’s School of Medicine.

September 1st at 1 pm, don’t miss João Frei “When the Brain Sleeps, Microglia Listen: Responses to MCH Neuron Activity” at the A0.02 auditorium in UMinho’s School of Medicine.

September 8th at 1 pm, don’t miss Marta Araújo “Elucidation of the Functional Roles of Lipid Metabolism During Leishmaniasis” at the A0.02 auditorium in UMinho’s School of Medicine.

September 15th at 1 pm, don’t miss Tatiana Fernandes “Unravelling the role of itaconate in the immunometabolic regulation of antifungal immunity” at the A0.02 auditorium in UMinho’s School of Medicine.

September 22nd at 1 pm, don’t miss Ana Clara Faria "Cholinergic dynamics of projections from Laterodorsal Tegmentum to the Nucleus Accumbens in associative learning" at the A0.02 auditorium in UMinho’s School of Medicine.

September 29th at 1 pm, don’t miss Mariana Ferreira “Sleep and MCH-neuron impact on microglia-Aβ plaque dynamics” at the A0.02 auditorium in UMinho’s School of Medicine.

October 2nd at 1 pm, don’t miss Bruno Almeida's "IPLEXMED: Driving the Next Generation of Diagnostics from Lab to Life" at the A0.03 auditorium in UMinho’s School of Medicine. IPLEXMED, a spin-off from the University of Minho and INL, is developing NEXAGUARD®—a portable, graphene-based diagnostic platform delivering lab-quality results in 20 minutes at the point of care or at home. Validated at TRL 6 with multiple patents filed, it targets bacterial respiratory infections and AMR, with plans to expand to STDs, sepsis, and hospital-acquired infections. Market launch is set for 2027 with a scalable “razor-and-blade” model, driving faster diagnostics, improved…